Literature DB >> 22719071

Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7.

Can Liu1, Kevin Kelnar, Alexander V Vlassov, David Brown, Junchen Wang, Dean G Tang.   

Abstract

MiRNAs regulate cancer cells, but their potential effects on cancer stem/progenitor cells are still being explored. In this study, we used quantitative real-time-PCR to define miRNA expression patterns in various stem/progenitor cell populations in prostate cancer, including CD44+, CD133+, integrin α2β1+, and side population cells. We identified distinct and common patterns in these different tumorigenic cell subsets. Multiple tumor-suppressive miRNAs were downregulated coordinately in several prostate cancer stem/progenitor cell populations, namely, miR-34a, let-7b, miR-106a, and miR-141, whereas miR-301 and miR-452 were commonly overexpressed. The let-7 overexpression inhibited prostate cancer cell proliferation and clonal expansion in vitro and tumor regeneration in vivo. In addition, let-7 and miR-34a exerted differential inhibitory effects in prostate cancer cells, with miR-34a inducing G1 phase cell-cycle arrest accompanied by cell senescence and let-7 inducing G2-M phase cell-cycle arrest without senescence. Taken together, our findings define distinct miRNA expression patterns that coordinately regulate the tumorigenicity of prostate cancer cells. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22719071      PMCID: PMC3872033          DOI: 10.1158/0008-5472.CAN-11-3864

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

Review 1.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

3.  DIANA-mirPath: Integrating human and mouse microRNAs in pathways.

Authors:  G L Papadopoulos; P Alexiou; M Maragkakis; M Reczko; A G Hatzigeorgiou
Journal:  Bioinformatics       Date:  2009-05-12       Impact factor: 6.937

Review 4.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

5.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

6.  Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.

Authors:  L Patrawala; T Calhoun; R Schneider-Broussard; H Li; B Bhatia; S Tang; J G Reilly; D Chandra; J Zhou; K Claypool; L Coghlan; D G Tang
Journal:  Oncogene       Date:  2006-03-16       Impact factor: 9.867

7.  Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.

Authors:  Lubna Patrawala; Tammy Calhoun; Robin Schneider-Broussard; Jianjun Zhou; Kent Claypool; Dean G Tang
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

8.  Methodologies in assaying prostate cancer stem cells.

Authors:  Hangwen Li; Ming Jiang; Sofia Honorio; Lubna Patrawala; Collene R Jeter; Tammy Calhoun-Davis; Simon W Hayward; Dean G Tang
Journal:  Methods Mol Biol       Date:  2009

9.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.

Authors:  M A Goodell; K Brose; G Paradis; A S Conner; R C Mulligan
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  99 in total

1.  Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.

Authors:  C Coarfa; W Fiskus; V K Eedunuri; K Rajapakshe; C Foley; S A Chew; S S Shah; C Geng; J Shou; J S Mohamed; B W O'Malley; N Mitsiades
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

Review 2.  Missing link between microRNA and prostate cancer.

Authors:  Balraj Singh Gill; Jimi Marin Alex; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2016-01-28

Review 3.  Signaling-mediated regulation of MicroRNA processing.

Authors:  Jia Shen; Mien-Chie Hung
Journal:  Cancer Res       Date:  2015-02-06       Impact factor: 12.701

4.  Effects of let-7c on the proliferation of ovarian carcinoma cells by targeted regulation of CDC25a gene expression.

Authors:  Wei Zhang; Qingru Zeng; Zhenying Ban; Jing Cao; Tianjiao Chu; Dongmei Lei; Chi Liu; Wentao Guo; Xianxu Zeng
Journal:  Oncol Lett       Date:  2018-08-20       Impact factor: 2.967

5.  Targeted therapy against cancer stem cells.

Authors:  Tao Yang; Kiera Rycaj
Journal:  Oncol Lett       Date:  2015-05-04       Impact factor: 2.967

Review 6.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

Review 7.  Concise Review: Prostate Cancer Stem Cells: Current Understanding.

Authors:  Sergej Skvortsov; Ira-Ida Skvortsova; Dean G Tang; Anna Dubrovska
Journal:  Stem Cells       Date:  2018-08-27       Impact factor: 6.277

8.  Prostate cancer biomarker: a key field to explore.

Authors:  Jianqing Lin; Hushan Yang; William K Kelly
Journal:  Asian J Androl       Date:  2013-02-25       Impact factor: 3.285

9.  Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic.

Authors:  Ntube N O Ngalame; Erik J Tokar; Rachel J Person; Yuanyuan Xu; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2014-01-15       Impact factor: 4.849

Review 10.  Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.

Authors:  Qu Deng; Dean G Tang
Journal:  Endocr Relat Cancer       Date:  2015-08-18       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.